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Introduction
(group F ), FGF2-neutralizing antibody (group M ) or the same volume of physiological saline (group C ) was Recent studies point to an important role for podocytes injected for 4 days via the tail vein, and the animals in the physiology and pathophysiology of the glomerwere sacrificed on the 25th day after the start of PAN ulus. With regard to the pathogenesis of developing administration. Proteinuria markedly increased in segmental glomerulosclerotic lesions, we [1] , as well as group F. The difference in proteinuria excretion was others [2] , previously reported that podocytes initially prominent on day 25. When the cell proliferation was detached themselves from the glomerular basement actually assessed by staining with proliferating cell membrane (GBM ), leading to the development of nuclear antigen (PCNA) antibody, PCNA-positive adhesions between the denuded membrane and cells clearly increased in group F, while they were Bowman's capsule. Proliferation of epithelial cells of suppressed in group M. PCNA-positive cells were Bowman's capsule and an extracellular matrix can be made up mainly of podocytes and epithelial cells of observed in these lesions. Therefore, adhesive lesions Bowman's capsule. When a comparison was made show morphological changes in the glomerulus after of podocyte damage using an anti-desmin monoclonal podocyte injury.
antibody as the marker of podocyte injury, the desmin score was lower in group M than in the other two
How does this mechanism contribute to adhesive groups. Adhesive lesions were most common in
lesions?
group F, while they were less prominent in group M. It is assumed that FGF2 was involved in the formation Our study is designed to find what promotes the of adhesive lesions due to proliferation of epithelial proliferation of epithelial cells in Bowman's capsule. cells of Bowman's capsule, since FGF2 administration It has been reported recently that fibroblast growth caused an increase in PCNA-positive epithelial cells of factor 2 ( FGF2) has a proliferative effect on cultured Bowman's capsule and administration of the neutraglomerular epithelial cells [3] . Our study focused on lizing antibody inhibited the formation of adhesive the role of FGF2 in the formation of glomerular glomeruli. Furthermore, these findings indicate the adhesive lesions. Animal models with glomerular possibility that FGF2 will induce the podocyte injury. adhesive lesions were prepared by administering puromycin aminonucleoside (PAN ). In normal glomeruli, FGF2 staining was detected at the GBM and in the Why does FGF2 accelerate podocyte injury? mesangial areas. However, an increase of FGF2 staining in the cytoplasm of podocytes was observed in In contrast to mesangial cells and glomerular endothelial cells, podocytes have little proliferative capacity in PAN nephropathy. Furthermore, FGF2 and FGFR 1-4 mRNAs were observed in both podocytes and vivo. The current consensus is that the mature podocyte is able to carry out limited DNA synthesis, but is epithelial cells of Bowman's capsule. These findings suggest that FGF2 has an important role in the forma-unable to undergo cell division [5] . Our study attempted to compare PCNA-positive cells and bromotion of glomerular adhesive lesions. Labelling with BrdU was done twice a day in the last week before sacrifice. With the Thy1 GN model, the number of BrdU-positive mesangial cells was evidently greater than that of PCNA-positive cells on day 7, during which the mesangial proliferative phase occurs. With PAN nephropathy, the number of podocytes was larger than that of BrdU-positive cells. In FGF2-administered PAN rats, the number of PCNA-positive and BrdU-positive podocytes increased. Furthermore, the difference in the number of these markers was noted. PCNA recognizes cells from the late G 1 to the early G 2 phase of the cell cycle, and BrdU recognizes cells in the S phase. Using this BrdU labelling method, the findings suggest that podocytes are mostly present in the late G 1 phase of the cell cycle even in the proliferative state, and that there is no increase in the number of cells. These findings showed that FGF2-induced podocyte What is the mechanism whereby podocytes in PAN Conclusions rats administered FGF2 remain in the late G 1 phase of the cell cycle?
Podocytes have little ability to synthesize new DNA in vivo, and tend to remain in the late G 1 phase of the cell As regards the cyclin kinase inhibitor (CKI ) family, cycle in the proliferative state with FGF2 added. A which suppresses the shifting of the cell cycle from the few podocytes entered the DNA synthesis phase. G 1 to the S phase, p21 and p27 are known [6 ] . Furthermore, some podocytes prominently showed biTherefore, in our study, the presence of p21 and p27 or multi-nucleated cells in PAN rats given FGF2 was analysed histochemically in PAN nephropathy. (Figure 1 ). This finding indicated that some podocytes With regard to the number of p27-positive cells in might have entered the M phase. Our hypothesis is that podocytes, changes due to administration of FGF2 were podocytes entering the S phase are associated with not observed. However, an increase in p21-positive FGF2-induced cell damages. Furthermore, it is necespodocytes was noted. There was, however, no difference sary to examine the lifetime of bi-or multi-nucleated histochemically in p21 expression between the PAN rats podocytes, and conduct a more detailed study of the which were given FGF2 and those which were not. blocking mechanism in the G 1 /S and M phases of the When the two sets of PAN rats were compared, the cell cycle. number of BrdU-positive cells was clearly greater in the rats administered FGF2. However, the number of podoAcknowledgements. This study was supported, in part, by Grants-incytes did not increase. This finding suggests that the aid for Scientific Research from the Ministry of Education, Science cause of most podocytes remaining in the late G 1 phase and Culture, Japan and by a project grant from Kawasaki Medical might be upregulation of p21. Furthermore, FGF2-School. induced podocyte injury related to cell cycle transit.
